Table 3.
Low dose | Medium dose | High dose | ||||
---|---|---|---|---|---|---|
|
|
|
||||
Samples | Conc. (mg/mL) | Predicted class | Conc. (mg/mL) | Predicted class | Conc. (mg/mL) | Predicted class |
NGTXC | ||||||
Acetamide | 300 | 0(*) | 1000 | 0(*) | 200 | 0(*) |
Carbamazepine | 30 | 0(*) | 100 | 0(*) | 300 | NGTX |
Carbon tetrachloride | 30 | 0(*) | 100 | 0(*) | 300 | 0(*) |
Clofibrate | 30 | 0(*) | 100 | 0(*) | 300 | NGTX |
Ethinylestradiol | 1 | 0(*) | 3 | NGTX | 10 | NGTX |
Fenofibrate | 10 | 0(*) | 100 | NGTX | 100 | NGTX |
Gemfibrozil | 30 | NGTX | 100 | NGTX | 300 | NGTX |
Methapyrilene | 10 | 0(*) | 30 | 0(*) | 100 | 0(*) |
Methyltestosterone | 30 | 0(*) | 100 | 0(*) | 300 | 0(*) |
Monocrotaline | 3 | 0(*) | 10 | 0(*) | 30 | 0(*) |
Phenobarbital | 10 | 0(*) | 30 | 0(*) | 100 | NGTX |
Thioacetamide | 4.5 | 0(*) | 15 | NGTX | 45 | NGTX |
WY-14643 | 10 | NGTX | 30 | NGTX | 100 | NGTX |
| ||||||
GTX | ||||||
Acetamidofluorene | 30 | 0 | 100 | 0 | 300 | 0 |
Carboplatin | 1 | 0 | 3 | 0 | 10 | 0 |
Colchicine | 0.5 | 0 | 1.5 | 0 | 5 | 0 |
Doxorubicin | 0.1 | 0 | 0.3 | 0 | 1 | 0 |
Lomustine | 0.6 | 0 | 2 | 0 | 6 | 0 |
Naphthyl isothiocyanate | 1.5 | 0 | 5 | 0 | 15 | 0 |
Tamoxifen | 6 | 0 | 20 | 0 | 60 | 0 |
| ||||||
Non-Hepatocarcinogen | ||||||
Acetaminophen | 300 | 0 | 600 | 0 | 1000 | 0 |
Allyl alcohol | 3 | 0 | 10 | 0 | 30 | 0 |
Amiodarone | 20 | 0 | 60 | 0 | 200 | 0 |
Aspirin | 45 | 0 | 150 | 0 | 450 | 0 |
Caffeine | 10 | 0 | 30 | 0 | 100 | 0 |
Diclofenac | 1 | 0 | 3 | 0 | 10 | 0 |
Erythromycin ethylsuccinate | 100 | 0 | 300 | 0 | 1000 | 0 |
Ethanol | 400 | 0 | 1200 | 0 | 4000 | 0 |
Gentamicin | 10 | 0 | 30 | 0 | 100 | 0 |
Nimesulide | 10 | 0 | 30 | 0 | 100 | 0 |
Promethazine | 20 | 0 | 60 | 0 | 200 | 0 |
Tannic acid | 100 | 0 | 300 | 0 | 1000 | 0 |
Tetracycline | 100 | 0 | 300 | 0 | 1000 | 0 |
Misclassified.